U.S. Markets close in 11 mins.

Shire plc (SHPG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
187.62-1.52 (-0.80%)
As of 3:49PM EDT. Market open.
People also watch
Interactive chart
Previous Close189.14
Bid187.63 x 100
Ask187.70 x 100
Day's Range187.38 - 190.37
52 Week Range161.09 - 209.22
Avg. Volume981,332
Market Cap55.17B
PE Ratio (TTM)192.43
Earnings DateN/A
Dividend & Yield0.91 (0.48%)
Ex-Dividend Date2017-03-08
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals3 hours ago

    Shire and tiny Lexington biotech say hemophilia drug trial misses mark

    Shares of Xenetic Biosciences sank on Monday after the Lexington biotech announced a significant setback in its collaboration with Shire plc on a hemophilia drug. Xenetic (XBIO), which has seven employees, announced disappointing results from a Phase 1/2 study of Shire’s SHP656 hemophilia A treatment using Xenetic’s PolyXen technology, which is designed to extend the half-life of drugs. While the technology did extend the half-life of SHP656, and there were no major side effects, Xenetic said the trial had missed its goal of enabling once-weekly dosing.

  • Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
    Zacks3 days ago

    Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug

    Shire plc (SHPG) announced positive top-line results from the phase III study, HELP, on HAE candidate, lanadelumab.

  • Zacks3 days ago

    Company News for May 19, 2017

    Companies in the News are: LB,P,INCY,MRK,SHPG